chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Administered Adult Form of Hepatitis B.  Because Patient is 16, I referred to CDC for infomation on how to proceed with next doses.  I was told to count this dose and give the Adolescent formula for the next 2 in the series.  I was also told to report this to the Adverse Event Reporting System
15 minutes after vaccine given call by nurse, because child was not feeling ok, he said that he felt like coughing after vaccine given in upper part of left arm (HPV). Mother noticed rash. His lungs and heart ok. This morning he was not feeling well and sent to ER.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 29Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 65 years, in right arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 21May2022 as dose 4 (booster), single (Batch/Lot number: unknown), in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing), notes: Other medical history: asthma; "known allergies: Sulfa drugs" (unspecified if ongoing), notes: known allergies: Sulfa drugs. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, suspected covid-19.The patient received Paxlovid, from 08Jul2022 to 12Jul2022 for treatment of COVID-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Urinary Tract Infection  Narrative:  Hospitalized for treatment of urinary tract infection that appeared after administration of COVID-19 vaccine. Second COVID-19 vaccine delayed due to hospitalization
Patient completed the COVID-19 Vaccine Screening and Consent Form and reported that he had not previously received a dose of any COVID-19 vaccine.  The dose of Janssen vaccine was administered 6/30/21 at 11:46am without incident.  At A Health office, we searched the  Department of State Health Services data base and found a record that the patient had received a dose of the Pfizer vaccine on 5/25/2021.  The patient did not report this previous dose.
Pt presents 2 days post injection with (R) deltoid red, sore, slightly swollen. No fever. Appx 12cmx21cm area. Applied BENADRYL cream & instructed to take TYLENOL. Drew border with sharpie & told them to call back if area grows > 1/2 inch outside border. Also told can take oral BENADRYL and put steroid cream & ice later on that day.
This solicited report was received from a physician, referring to a 15 year old female patient, who was enrolled in a Market Research.  The patient did not have concurrent condition and concomitant therapies. The patient's medical history was not provided. On an unknown date, the patient was vaccinated with a dose of GARDASIL (subcutaneous; lot#, expiration date and dose unknown) for prophylaxis. On an unknown date in 2000 or 2010, the patient was fainted, and it was considered as an expected and common side effect.  No diagnostic test was carried out. The outcome of event was reported as recovered with sequelae. It was reported that the event did not re-appear after re-vaccinating GARDASIL. The causality between event  "fainted" and GARDASIL was reported as related. Additional information has been requested.
04/03/2021 08:00AM, when I woke, my right arm was numb. (The opposite arm from the injection site.) That symptom continued for about 6 months. It lasts 20-20 minutes every morning and then it goes away for the day until the next morning. On April 19, 2021, I had a CRP test done for inflammation. Normal range is 1-10. My number was 69. My body was inflamed and swollen. After each vaccine, there is a period that I am extremely inflamed and swollen.
On 11/08/2018 (Thursday) Employee experienced potential allergic reaction to the Influenza vaccine she received on 11/07/2018 (Wednesday). She sated that Thursday evening she developed rash on the upper extremity Influenza vaccine was given. She reports rash started at the hand and moved upwards, by 11/09/2018 Friday morning she had rash on her cheeks, neck and upper chest. She stated she did not change her cosmetics, soaps, or laundry detergents, she also denies any food allergies or any previous allergy to influenza vaccination. She did see MD at urgent care, was given ALLEGRA and her symptoms went away within 2 days.
Patient c/o fever, pain to the site redness and diarrhea x 2 days.
A 13 year old patient was administered a dose of Moderna .25cc. There was no adverse reaction and no negative symptoms.
Upper arm, swelled, red, hot to touch, bruising, painful, skin now peeling. (When to doctor after reaction) scar at injection site now.
Stomach pain in the middle of the night (12 hours post vaccine) and started my my period randomly 36 hours  after shot.
Flare of her Hashimoto disease; Flare of her Hashimoto disease; She has been under increased stress of late; This is a spontaneous report from a contactable consumer. A 46-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. Medical history included ongoing rheumatoid arthritis and ongoing Hashimoto's disease. Concomitant medications included prednisone, etanercept (ENBREL) taken for rheumatoid arthritis. The patient had been under increased stress of late and had a flare of her Hashimoto disease after receiving the second dose of the COVID vaccine. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Chief Complaint This patient is a pleasant 92-year-old elderly lady who has been awake alert oriented x4 currently living at home with her daughter was brought in after she had runny nose sore throat and felt congested unwell.  Symptom onset was 2 to 3 days ago no sick contact no history of recent travel She has been adequately immunized with 2 injections of Pfizer.  dISCHARGE nOTE:   Discharge Diagnosis Acute symptomatic COVID-19 patient brought in admitted improved and has been on room air Being discharged home in stable condition with family
Intestinal virus; Stomach bug; This spontaneous case was reported by a consumer and describes the occurrence of GASTROINTESTINAL INFECTION (Intestinal virus) and GASTROENTERITIS VIRAL (Stomach bug) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced GASTROINTESTINAL INFECTION (Intestinal virus) and GASTROENTERITIS VIRAL (Stomach bug). At the time of the report, GASTROINTESTINAL INFECTION (Intestinal virus) and GASTROENTERITIS VIRAL (Stomach bug) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
09/07/22 presents to ED for "fever". PMHx of "hypertension, diabetes, pancreatitis, alcoholic cirrhosis, cholangiocarcinoma"
On 9th day following vaccination, I developed swelling, redness, itching and induration at the injection site. Also experiencing headache and spike in blood pressure, not sure whether related or not.
Information has been received from a nurse practitioner concerning an 18 year old female who on 13-MAY-2008 was vaccinated intramuscularly in the left deltoid with her first dose of GARDASIL vaccine (yeast) (lot# not reported). Subsequently the mother called the office on 04-JUN-2008 because the patient experienced cervical, groin and bilateral axillary lymphadenopathy on an unspecified date. Subsequently, the patient recovered from cervical, groin and bilateral axillary lymphadenopathy on an unspecified date. Additional information has been requested.
Routine immunizations administered on 5/29/01. Seizure activity on 5/30/01, cared for by EMS. Rechecked in office on 5/30/01. Treatment: observation, Tylenol every 4 hours, fluids and rest.
After 2nd injection, patient reported a fever; red area at the site of injection the size of an orange but never raised/ Red site, but not raised as the first one was; the patient was itchy all over about1/2 hour, which resolved without intervention.; This is a spontaneous report from a contactable pharmacist. A 54-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: not reported), dose 2 via Intramuscular, administered in Arm Right on 20Jan2021 (at the age of 54-years-old) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient was allergic to latex and Tdap. The patient had same reaction when received a prior tetanus containing vaccine. Exact product was unknown. Environmental allergy history, Demarol/Augmentin- listed as allergies but only due to adverse effects not true allergies. The patient taking Cardia Lisinopril prior to the event being reported. Historical vaccine included bnt162b2 in the left arm on 30Dec2020 as 1st dose for Covid-19 immunization and experienced injection site was still sore and tender and Red and itchy eyes. On an unspecified date, the patient experienced after 2nd injection, patient reported a fever, red area at the site of injection the size of an orange but never raised/ red site, but not raised as the first one was, the patient was itchy all over about1/2 hour, which resolved without intervention.  It was reported that the Pfizer product had a causal effect to the adverse event. Reaction DID not recur on re-administration of product. Vaccination Facility type was a Hospital. After 2nd injection, patient reported a fever and red area at the site of injection the size of an orange but never raised. Subsequently a few days later, the patient was itchy all over about1/2 hour, which resolved without intervention. The patient received treatment with Cephalaxin 500 PO QID x 7 d. No laboratory tests or diagnostic studies was performed. The patient received no other vaccines for any other conditions prior to the event being reported. The patient received no other vaccines for SARS-CoV2 other than Pfizer-BioNTech COVID-19 Vaccine prior to the event being reported. The patient received no other vaccines around the time of Pfizer-BioNTech COVID-19 Vaccine vaccination. None of the AEs require a visit to Emergency Room. Prior vaccinations within 4 weeks was none.  Outcome of the events fever and redness was unknown, and the outcome of the other event was recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
wheezing/ tight chest; wheezing/ tight chest; extremely itchy rash on feet, palms of hands; fever; This spontaneous case was reported by a patient family member or friend and describes the occurrence of WHEEZING (wheezing/ tight chest), CHEST DISCOMFORT (wheezing/ tight chest), RASH PRURITIC (extremely itchy rash on feet, palms of hands) and PYREXIA (fever) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 09-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-May-2021, the patient experienced WHEEZING (wheezing/ tight chest), CHEST DISCOMFORT (wheezing/ tight chest), RASH PRURITIC (extremely itchy rash on feet, palms of hands) and PYREXIA (fever). The patient was treated with IBUPROFEN at a dose of 1 dosage form. At the time of the report, WHEEZING (wheezing/ tight chest), CHEST DISCOMFORT (wheezing/ tight chest), RASH PRURITIC (extremely itchy rash on feet, palms of hands) and PYREXIA (fever) outcome was unknown.            No relevant concomitant medications were provided. Patient had been to urgent care (who tested her for COVID) who was unable to distinguish what was wrong. She went to emergency room at Rhode Island Hospital. They performed test and they ran test on her (x-ray due to wheezing/ tight chest). They said they were sure that it had nothing to do with the vaccine.  Company comment: Very limited information regarding the events has been provided at this time. Further information has been requested.   Patient went to emergency room and they said they were sure that it had nothing to do with the vaccine.; Sender's Comments: Very limited information regarding the events has been provided at this time. Further information has been requested.
Patient began having headache and fatigue 12/29. Early morning of 12/30 patient reported severe chills. Felt better during the day of 12/30 with only a headache. Night of 12/30 patient reported severe chills again and wanted to call the doctor in the morning, but the felt better on 12/31. The night of 12/31 patient again had chills, but less severe (rated 3/10 on scale).  Night of 1/1 patient reported slight hive like rash that went away with warm Epsom salt bath. 1/3  0100 patient woke up with severe hives down back of legs and lower back.  Got into a hot tub to soak and once the patient got out he was standing at the sink and passed out. His wife got him back to bed. Around 0700 on 1/3 patient woke up to urinate and he  passed out again. He states both times he passed out felt the same stating "I felt like I was going to vomit and then all of a sudden I couldn?t breath, almost like I was choked out."
PATIENT RECEIVED HER 3RD DOSE OF PFIZER. PATIENT WAS SITTING IN OBSERVATION AND 5 MINUTES INTO OBSERVATION SHE REPORTS FEELING LIGHTHEADED AND DIZZY. RN ADVISED HER TO LAY ON THE FLOOR WITH HER FEET ELEVATED. PATIENT REPORTS DIZZINESS GETTING BETTER WHEN LYING DOWN AND FEET ELEVATED. VITALS WHEN LYING DOWN INITIALLY WAS 108/65, HR 66, 99% O2, 5 MIN LATER VITALS WERE 105/65, HR 65 99% O2. PATIENT REPORTS HER LAST MEAL WAS 2 PM. AFTER ABOUT 10 MINUTES HER DIZZINESS SUBSIDED AND SHE WAS ABLE TO SIT UP SLOWLY. VITALS AT THIS TIME WERE 120/89, HR 75. SHE WAS GIVEN A SNACK TO EAT AND COLD BEVERAGE. PATIENT REPORTS FEELING MUCH BETTER AT THIS TIME. SHE ALSO REPORTS NOT TAKING HER LEXAPRO PRIOR TO COMING IN TO GET HER VACCINE. MOM STATES SHE HAS A PHOBIA OF NEEDLES WHICH WAS NEVER MENTIONED UP UNTIL THIS EVENT. PATIENT COMPLETED HER OBSERVATION PERIOD AND WAS ABLE TO INDEPENDENTLY AMBULATE OUT OF THE FACILITY WITH NO ACUTE ISSUES; SHE WAS STABLE AT THIS TIME.
Took oral typhoid vaccine (Ty 21A) on 6/9, 6/11, 6/13 and 6/15. On 6/15/08 developed bilateral hives on elbows/knees and knuckles. Given 50mg Benadryl with resolution of hives. Seen on 6/16/08 by pediatrician who ordered OTC Zyrtec x 2 days.
Patient started to feel dizzied and fainted after receiving vaccines. He turn yellowish/green and started to sweat. He was unconscious for 5 seconds approximately. We checked blood sugar levels (89). We called 911 and they did an EKG and repeat blood sugar test. All result were within normal range.
Information has been received from a physician concerning a 41 year old white father with no known drug allergies who's 12 month old daughter was vaccinated with a dose of varicella virus vaccine live "one week ago", on approximately 06/12/03.  There was no illness at the time of vaccination. On 06/19/03 the father developed herpes zoster. The physician is not certain if the zoster was transmitted from the vaccine. No other information was given.  Unspecified medical attention was sought. There was no product quality complaint. Follow up information received from a physician indicated that the adverse event onset was 06/16/03.  It was noted that the "pt is father of child immunized within 2 weeks prior to presentation of zoster". The reporter indicated that no additional data was available. It was noted that the pt recovered.  No additional information is expected.
1 week in bed due to fever, chills, aches, fatigue, vomiting, red swollen arm.  Did not have similar reaction to prior Moderna doses
Pt developed flu-like symptoms, the evening, post vax. Her left arm gradually started going numb on and off with tingling sensations. She reported chest pain and back pain (both have subsided). She also had pain in her left arm, as well as soreness. She said that there was a scab where the needle was inserted, even a few weeks after she had the injection. Currently, her left arm is having numb sensations on and off.
Systemic: Fainting / Unresponsive-Medium, Systemic: Seizure-Mild, Additional Details: About 1-2 minutes after IM injection, pt was seated in the chair and I was getting his paperwork together. Pt stopped talking, his head slumped back and he began having seizure like activity.  Pt was completely unresponsive for about 1 minute.  When patient came to, he was confused about where he was and what had happened.  911 was activated. Patient remained slightly confused, bradycardic, and diaphoretic while waiting on and once EMS had arrived. They started on IV and took him to the ER
After 30 minutes, pt c/o of being light headed and an itchy face.  Denied SOB or chest pain. Temp 36.4C HR 67 RR 17 B/P 172/108 ( pt believes he may have HTN- ) sat 98%. RA. Administered 25 mg of Benadryl PO and water. After 5 min pt reported feeling better, after fifteen min symptoms subsided, bp 153/103 HR 69. Pt advised to follow up with his PCP, maintain adequate hydration, avoid prolong sun-heat exposure, and rest as much as possible. Pt D/C home with co-worker (driver), ambulatory in stable condition.
Pt felt fatigued and nauseated after immunizations and for several days afterward.  Pt believes he also had fever.  These symptoms were mostly resolved as of 8/19/19.  After immunization, pt also developed small rash at injection site.  It has grown somewhat larger over last several days.  No other symptoms directly at injection site.  Pt has not received medical attention.
Severe aching and pain in upper right arm where vaccine was given. Difficulty/near impossible to position arm in various positions. Stiffness, soreness, aching, and shooting pain when attempt is made to place arm in various positions or at rest. Not treatment was requested or provided at this time.
Patient given vaccination at pharmacy around 11am Thursday 2/4/21. No problems at time of administration or 15 minutes following. Spouse reports patient experienced generalized weakness and joint pain at around 3am 2/5/21. She could "hardly get out of bed." They brought her to the ED and she was admitted to the hospital for observation. She was discharged on Sat 2/6/21 and sent home with Rx for prednisone.
INTENSE FULL BODY ITCHING 30 MINUTES POST-DOSE 1 OF COVID VACCINE.
similar reaction to the flu vaccine/Suspected vaccination failure; similar reaction to the flu vaccine; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Flu vaccine. On an unknown date, unknown after receiving Flu vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and influenza. On an unknown date, the outcome of the vaccination failure and influenza were unknown.   It was unknown if the reporter considered the vaccination failure and influenza to be related to Flu vaccine.     Additional Information: GSK receipt date: 23-May-2022 Reporter's comment: The case was received from patient's daughter-in-law via interactive digital media. The reporter stated that the patient had a similar reaction (got flu after vaccinated for them) to the flu vaccine, so they did not get that either nor did they ever get the flu. The reporter suggested that at least find out if you or a family member had ever had a vaccine reaction before risking it. So great you're questioning it versus just jumping on the bandwagon. Additional Supportive Information:  This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming influenza were unknown at the time of reporting. Follow-up could not be possible as no contact details were available. The case was linked with case US2022AMR084028, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR084028:Same reporter
09/28/2021, 2:30 PM, vaccines given, observed for the required amount of time in clinic, no adverse event. 09/29/2021, Patient called to report eyes swelling  when she woke up, no other signs or symptoms or swelling any where else. Patient was advised to take an antihistamine and call 911 or go to nearest Emergency Department for observation and further management. 09/30/2021 Patient report took an antihistamine and all symptoms resolved so she did not go. report continued to be symptoms free. refused doctor's visit.
Patient fainted 25 minutes after receiving the vaccine.  He was seated at the time, and fell forward out of his chair.  He hit his head on the hard floor.  The medical staff on site treated him and called for EMS.  He was taken by ambulance to the hospital because of a continued low blood pressure and to rule out any problems due to hitting his head.
Face became itchy / Whole body became itchy; Hive in random places; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 07Apr2021 at 10:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to nuts, egg, shellfish, peanut, coconut and pet dander. Concomitant medications included fluticasone (MANUFACTURER UNKNOWN) and norethidrone acetate-ethinylestradiol (MANUFACTURER UNKNOWN), both taken for unspecified indications from unknown dates. The patient previously took amoxicillin and tramadol and experienced drug allergy with both. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 11:00, about 30 minutes after the vaccination, the patient experienced that her face became itchy, over the next 3 hours her whole body became itchy, there was no visible rash and she had hives in random places (two on face, one on neck, one on back, one in armpit). Even after 9 hours the patient felt itchy. On an unknown date, the patient underwent COVID-19 test (nasal swab) and the result was negative. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events face and whole body were itchy and hives were resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.